Why Vera Therapeutics Stock Soared by 22% This Week
Executive changes and a bullish analyst take combined to boost sentiment on the company.
Stay updated with breaking news from Celia Lin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Executive changes and a bullish analyst take combined to boost sentiment on the company.
Vera Therapeutics, Inc. announced the appointments of two industry veterans to help lead the development of the company?s drug programs including its late-stage product candidate, atacicept, to treat...
BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and...
New analysis of Phase 2a JANUS clinical trial showed atacicept reduced immune complex levels in patients with IgA nephropathy (IgAN)Atacicept is the first...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.